arrow
A

Andrew Mulato

discovery virology, gilead sciences, inc., 333 lakeside dr., foster city, california 94404, united states
H指数:24
被引数:3,131

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis

Lenacapavir的发现:首个每半年给药一次的衣壳抑制剂,用于HIV-1治疗和暴露前预防

2025-10-010
OAAI
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability

具有改善的代谢稳定性的非肽模拟HIV蛋白酶抑制剂的临床前表征

2024-04-031
OAAI
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model
2019-09-09105
OAAI
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile
2016-12-01253
OAAI
In Vitro Characterization of GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile
2011-04-0131
OAAI